Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
about
Interval debulking surgery for advanced epithelial ovarian cancerInterval debulking surgery for advanced epithelial ovarian cancerChemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancerInterval debulking surgery for advanced epithelial ovarian cancerChemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancerNeoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma.A meta-analysis: neoadjuvant chemotherapy versus primary surgery in ovarian carcinoma FIGO stageIII and IV.Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients.Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study.Current management of epithelial ovarian carcinoma: a review.Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy.The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer.Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009.Cytologic changes of ovarian epithelial cancer induced by neoadjuvant chemotherapyThe role of surgery in the management of epithelial ovarian cancer.Neoadjuvant chemotherapy for advanced ovarian cancer: overview of outcomes and unanswered questions.Neoadjuvant chemotherapy equalizes the optimal cytoreduction rate to primary surgery without improving survival in advanced ovarian cancer.Prospective randomized trials on cytoreduction in ovarian cancer.Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery.
P2860
Q24186533-64809200-A86C-4568-A390-8E906FF2B482Q24197813-1ED271EE-4DEA-4C50-86E0-837F95635101Q24201686-173E010F-4CD9-41B3-9609-2D066EF9B7DDQ24234696-8EB0F20A-D042-4F85-B4D6-7A6240C61152Q24242912-C37361FE-5D67-4A52-B64D-9ACBAD20A88FQ24817101-1FC5459D-6EA5-4038-BB0B-3F5844B8378AQ31141618-2292E4CC-F18E-49D4-82C6-5D5A0CD037BEQ33246043-D0E84B25-1794-474B-8CFE-CFD68C783A0EQ33724835-15F70619-89AE-476C-882C-06BD7F931A1DQ33959810-68FC9AED-9DFE-48AD-819C-F1903A9E601CQ34121226-233B1D1A-43E8-4328-A81C-CCA5E50252D9Q34389383-AF293A45-ADD7-4E25-AD3E-E3A78F48517BQ36089005-E716F3CC-8840-4A5C-BECA-E261FAE50275Q36443934-6CBC5D69-AD9F-4542-85B0-F7275BAEA068Q37228849-3DC72F67-93F8-49CC-818E-50599542DB20Q37832930-A59CEC34-A9A3-4261-B002-F97A76430739Q37909365-C608FEC6-AAAD-47DC-AE01-1C826CEB4A95Q39401023-3386A8F1-51FC-47FF-8BB0-540ABFD79E1EQ49279474-0F9FD147-246C-4D2B-B22B-9595D0EDA893Q53260742-B689AF95-8954-424E-930F-CD30842625EC
P2860
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
@en
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
@nl
type
label
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
@en
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
@nl
prefLabel
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
@en
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
@nl
P2093
P1433
P1476
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
@en
P2093
P304
P356
10.1016/0090-8258(91)90335-3
P407
P577
1991-08-01T00:00:00Z